|
|
 |
|
Viewing report
|
|
|
|
Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma
GBI Research, Sep 2010, Pages: 89
Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma
Summary
GBI Research’s report, “Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the technology that shape the industry dynamics for the key geographies: the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and analyzes the licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Scope
The scope of this report includes -
- Annualized market data from 2001 to 2009, forecast forward to 2016.
- Analysis of the leading technology in this space
- Analysis of the leading technology in this space
- Market characterization
- Key drivers and barriers that have a significant impact on the market.
- Competitive benchmarking of leading companies.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
- Reinforce R&D pipelines
- Develop key strategic initiatives by understanding the key focus areas of leading companies.
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.
Customers who bought this item also bought
Acute Myeloid Leukemia Therapeutics Market (2010 – 2020) (Pipeline Assessment & Market Forecast In G8 Countries)
Leukemia Therapeutics Market (2010-2020) (Acute/Chronic lymphocytic leukemia & Acute/Chronic myeloid leukemia) Pipeline forecast & Market forecast in G8 countries
Pipeline Insight: Lymphomas, Multiple Myeloma & Myelodysplastic Syndromes - Optimization of clinical practice creates opportunities for emerging therapies
Global Acute Myeloid Leukemia Drug Pipeline Capsule - 2012
Blood Cancer Drug Discoveries: what the future holds
Pipeline Insight: Leukemias Underserved patient populations offer potential for market growth
Acute Lymphocytic Leukemia Therapeutics Market (2010 – 2020) (Pipeline Forecast & Market Forecast In G8 Countries)
Lymphoma Therapeutics - Global Strategic Business Report
Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2012
|
|
|
|
